Sutro Biopharma Inc buy Wedbush
Start price
14.11.23
/
50%
€2.08
Target price
14.11.24
€11.07
Performance (%)
50.96%
Price
03.10.24
€3.18
Summary
This prediction is currently active. The BUY prediction by Wedbush for Sutro Biopharma Inc has seen massive gains of 50.96%. This prediction currently runs until 14.11.24. The prediction end date can be changed by Wedbush at any time. Wedbush has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Sutro Biopharma Inc | 2.581% | 2.581% |
iShares Core DAX® | -1.114% | 3.430% |
iShares Nasdaq 100 | 1.816% | 6.911% |
iShares Nikkei 225® | 2.113% | 5.501% |
iShares S&P 500 | 2.038% | 5.327% |
Comments by Wedbush for this prediction
In the thread Sutro Biopharma Inc diskutieren
Sutro Biopharma, Inc. (NASDAQ: STRO) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $12.00 price target on the stock.
Ratings data for STRO provided by MarketBeat
Stopped prediction by Wedbush for Sutro Biopharma Inc
Sutro Biopharma Inc
Start price
Target price
Perf. (%)
€3.84
14.05.24
14.05.24
€7.40
14.05.25
14.05.25
-19.79%
03.10.24
03.10.24
Sutro Biopharma Inc
Start price
Target price
Perf. (%)
€4.78
03.04.24
03.04.24
€7.38
03.04.25
03.04.25
-34.31%
03.10.24
03.10.24
Sutro Biopharma Inc
Start price
Target price
Perf. (%)
€4.58
26.03.24
26.03.24
€7.38
26.03.25
26.03.25
-31.44%
03.10.24
03.10.24
Sutro Biopharma Inc
Start price
Target price
Perf. (%)
€2.72
23.10.23
23.10.23
€11.29
23.10.24
23.10.24
13.24%
03.10.24
03.10.24
Sutro Biopharma Inc
Start price
Target price
Perf. (%)
€3.86
11.08.23
11.08.23
€10.95
11.08.24
11.08.24
-26.94%
12.08.24
12.08.24